Robert Gerstl

Array ( [id] => 2763266 [patent_doc_number] => 04994478 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-02-19 [patent_title] => 'Oxadiazole derivative' [patent_app_type] => 1 [patent_app_number] => 7/357623 [patent_app_country] => US [patent_app_date] => 1989-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5142 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/994/04994478.pdf [firstpage_image] =>[orig_patent_app_number] => 357623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2579850 [patent_doc_number] => 04973699 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-11-27 [patent_title] => 'Cephem compounds and processes for preparation thereof' [patent_app_type] => 1 [patent_app_number] => 7/352989 [patent_app_country] => US [patent_app_date] => 1989-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35181 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/973/04973699.pdf [firstpage_image] =>[orig_patent_app_number] => 352989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2636675 [patent_doc_number] => 04910194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-03-20 [patent_title] => 'Thienotriazolodiazepine compounds and pharmaceutical uses thereof' [patent_app_type] => 1 [patent_app_number] => 7/352536 [patent_app_country] => US [patent_app_date] => 1989-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7344 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 339 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/910/04910194.pdf [firstpage_image] =>[orig_patent_app_number] => 352536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2681070 [patent_doc_number] => 05004752 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-04-02 [patent_title] => 'Novel 9-haloprostaglandins, processes for their preparation, and their use as medicinal agents' [patent_app_type] => 1 [patent_app_number] => 7/350951 [patent_app_country] => US [patent_app_date] => 1989-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2982 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/004/05004752.pdf [firstpage_image] =>[orig_patent_app_number] => 350951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2587124 [patent_doc_number] => 04963544 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-10-16 [patent_title] => '3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds' [patent_app_type] => 1 [patent_app_number] => 7/347579 [patent_app_country] => US [patent_app_date] => 1989-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15515 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/963/04963544.pdf [firstpage_image] =>[orig_patent_app_number] => 347579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2706404 [patent_doc_number] => 05001138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-03-19 [patent_title] => 'Novel heterocyclic compounds' [patent_app_type] => 1 [patent_app_number] => 7/347836 [patent_app_country] => US [patent_app_date] => 1989-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17857 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 857 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/001/05001138.pdf [firstpage_image] =>[orig_patent_app_number] => 347836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2671184 [patent_doc_number] => 04983596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-01-08 [patent_title] => '3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid derivatives and their preparation' [patent_app_type] => 1 [patent_app_number] => 7/347025 [patent_app_country] => US [patent_app_date] => 1989-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21769 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/983/04983596.pdf [firstpage_image] =>[orig_patent_app_number] => 347025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2597141 [patent_doc_number] => 04975446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-12-04 [patent_title] => 'Treatment of glaucoma' [patent_app_type] => 1 [patent_app_number] => 7/346493 [patent_app_country] => US [patent_app_date] => 1989-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5221 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/975/04975446.pdf [firstpage_image] =>[orig_patent_app_number] => 346493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2587010 [patent_doc_number] => 04908361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-03-13 [patent_title] => 'Tetrahydroisoquino(2,1-C)(1,3)benzodiazepines' [patent_app_type] => 1 [patent_app_number] => 7/344799 [patent_app_country] => US [patent_app_date] => 1989-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3283 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/908/04908361.pdf [firstpage_image] =>[orig_patent_app_number] => 344799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2647159 [patent_doc_number] => 04895862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-23 [patent_title] => 'Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents' [patent_app_type] => 1 [patent_app_number] => 7/341407 [patent_app_country] => US [patent_app_date] => 1989-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5418 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/895/04895862.pdf [firstpage_image] =>[orig_patent_app_number] => 341407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2628378 [patent_doc_number] => 04966975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-10-30 [patent_title] => 'Processes for the preparation of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents' [patent_app_type] => 1 [patent_app_number] => 7/341615 [patent_app_country] => US [patent_app_date] => 1989-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8365 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/966/04966975.pdf [firstpage_image] =>[orig_patent_app_number] => 341615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2556143 [patent_doc_number] => 04897405 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-30 [patent_title] => 'Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents' [patent_app_type] => 1 [patent_app_number] => 7/341340 [patent_app_country] => US [patent_app_date] => 1989-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13905 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/897/04897405.pdf [firstpage_image] =>[orig_patent_app_number] => 341340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2647138 [patent_doc_number] => 04895861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-23 [patent_title] => 'Novel naphthalenyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents' [patent_app_type] => 1 [patent_app_number] => 7/341609 [patent_app_country] => US [patent_app_date] => 1989-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9201 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/895/04895861.pdf [firstpage_image] =>[orig_patent_app_number] => 341609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2647120 [patent_doc_number] => 04895860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-23 [patent_title] => 'Novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides useful as anthihyperglycemic agents' [patent_app_type] => 1 [patent_app_number] => 7/341514 [patent_app_country] => US [patent_app_date] => 1989-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12936 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/895/04895860.pdf [firstpage_image] =>[orig_patent_app_number] => 341514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2737067 [patent_doc_number] => 04997949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-03-05 [patent_title] => 'Crystalline 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl) thiazole dihydrochloride trihydrate' [patent_app_type] => 1 [patent_app_number] => 7/365155 [patent_app_country] => US [patent_app_date] => 1989-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3062 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/997/04997949.pdf [firstpage_image] =>[orig_patent_app_number] => 365155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2737640 [patent_doc_number] => 04997981 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-03-05 [patent_title] => 'Processes for 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl) thiazole and analogs' [patent_app_type] => 1 [patent_app_number] => 7/424300 [patent_app_country] => US [patent_app_date] => 1989-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3081 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/997/04997981.pdf [firstpage_image] =>[orig_patent_app_number] => 424300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2709396 [patent_doc_number] => 05017572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-05-21 [patent_title] => 'Derivatives of 1-[3-(4-hydroxyphenyl) 1-hydroxy 1-propyl] benzene substituted in position 2 by an aminoalkyleneoxy chain, the method of preparing same and the application thereof to therapeutics' [patent_app_type] => 1 [patent_app_number] => 7/339815 [patent_app_country] => US [patent_app_date] => 1989-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8233 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/017/05017572.pdf [firstpage_image] =>[orig_patent_app_number] => 339815 [rel_patent_id] =>[rel_patent_doc_number] =>)